23andMe Lays Off 40% of Staff, Shuts Drug Development Business

HS 11/11/2024
Advertisements




The genetics company is closing a unit that was once seen as core to its future.



Source link

More Stories

Wholesale prices rose 1.1% in May, more than expected, on surge in energy

HS 11/06/2026

Elections advertising spend for 2026 expected to reach record high, outpacing presidential years

HS 11/06/2026

Beyond SpaceX: Here's where family offices see buying opportunities in the space economy

HS 11/06/2026

You may have missed

Stock futures tick higher as Wall Street gears up for SpaceX’s historic IPO: Live updates

HS 11/06/2026

Biggest-ever IPO: Retail investors line up, bid over $70 billion for SpaceX

HS 11/06/2026

CVS Health executives on reducing healthcare’s biggest pain points

HS 11/06/2026

SpaceX to close above $2 trillion market cap on its debut, prediction market traders say

HS 11/06/2026

Sleepless and streamless: Indian fans hit by broadcast glitches on World Cup Day 1

HS 11/06/2026